PB272

4 Top FDA Decisions Expected in Q1
24/7 Wall St
Mon, 01/4/16 - 10:05 am
FDA
Zafgen
beloranib
Biomarin
Peg-Pal
PB272
Puma Biotechnology
Aquinox
AQX-1125
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/1/14 - 11:33 am
Puma Biotechnology
PB272
breast cancer
HER2-positive metastatic breast cancer
Puma Biotechnology presents positive PB272 clinical data at ASCO
Yahoo/The Fly On The Wall
Sun, 06/3/12 - 11:07 am
Puma Biotechnology
PB272
breast cancer
Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Fierce Biotech
Fri, 12/9/11 - 11:59 am
Pfizer
Puma Biotechnology
breast cancer
neratinib
PB272